Pulmonx Corporation IPO Advisory
Share this IPO Profile:Smart Search
Company |
Symbol |
Price Range |
Issue Price |
Open |
Shares |
Trade Date |
| Pulmonx Corporation | LUNG - NASDAQ |
$17.00-$18.00 | $19.00 | $40.00 | 10 million | 10/1/2020 |
| BofA Securities, Morgan Stanley | ||||||
Co-Manager(s): Stifel, Wells Fargo Securities, Canaccord Genuity | ||||||
| Health Care | ||||||
Filing(s): 1st Filed 2020-02-28 Filed 2020-09-04 Terms Added 2020-09-24 Terms Changed 2020-09-30 | ||||||
Pulmonx Corporation Quote & Chart - Click for current quote - LUNG
IPO Boutique aggregates information on public companies and private companies, such as "LUNG" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.
About Pulmonx Corporation (adapted from Pulmonx Corporation prospectus):
They are a commercial-stage medical technology company that provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD).
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
They are a commercial-stage medical technology company that provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD).
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
IPO Boutique aggregates information on public companies and private companies, such as "LUNG" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.